检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Harnessing CD39 for the Treatment of Colorectal Cancer and Liver Metastases by Engineered T Cells

Alessia Potenza,Balestrieri Chiara,Luca Albarello,Federica Pedica,Martina Spiga,Francesco Manfredi,Beatrice Claudia C. Cianciotti,Claudia De lalla,Lorena Stasi,Elena Tassi,Silvia Bonfiglio, Giulia Scotti,Miriam Redegalli,Donatella Biancolini,Danilo Abbati,Fabio Simeoni,Dejan Lazarevic,Ugo Elmore,Guido Fiorentini, Giulia Di Lullo,Giulia Casorati,Claudio Doglioni,Giovanni Tonon,Paolo Dellabona,Riccardo Rosati,Luca Aldrighetti,Eliana Ruggiero,Chiara Bonini

Regular and Young Investigator Award Abstracts（2023）

引用 0|浏览14
暂无评分
摘要
HER-2-specific CD39 disrupted engineered T cells are promising advanced medicinal products for primary and metastatic CRC.
更多
查看译文
关键词
colorectal cancer, liver metastases, immunotherapy, cancer immunobiology, T lymphocytes
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要